Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | -2.31% | -6.03% | -40.80% |
Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 12.49M 13.84M | Sales 2025 * | 60.77M 67.35M | Capitalization | 250M 278M |
---|---|---|---|---|---|
Net income 2024 * | -62M -68.72M | Net income 2025 * | -24M -26.6M | EV / Sales 2024 * | 20.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-4.18
x | P/E ratio 2025 * |
-11.5
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.21% |
1 day | -2.31% | ||
1 week | -6.03% | ||
Current month | -18.23% | ||
1 month | -24.30% | ||
3 months | -38.84% | ||
6 months | +2.07% | ||
Current year | -40.80% |
Managers | Title | Age | Since |
---|---|---|---|
Andrea Pfeifer
FOU | Founder | 66 | 03-02-12 |
Director of Finance/CFO | 35 | 18-12-31 | |
Nuno Mendonça
CTO | Chief Tech/Sci/R&D Officer | 42 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Williams
CHM | Chairman | 66 | 17-12-31 |
Carl June
BRD | Director/Board Member | 70 | 20-11-19 |
Werner Lanthaler
BRD | Director/Board Member | 56 | 18-07-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.96 | -2.31% | 168,448 |
24-03-27 | 3.03 | +6.69% | 193,211 |
24-03-26 | 2.84 | -2.07% | 984,868 |
24-03-25 | 2.9 | -5.54% | 207,722 |
24-03-22 | 3.07 | -2.54% | 260,750 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.80% | 278M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |